The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms. (LEFT-APP)
Gastroesophageal Reflux, Heartburn
About this trial
This is an interventional treatment trial for Gastroesophageal Reflux focused on measuring Sleep positional therapy
Eligibility Criteria
Inclusion Criteria: Written informed consent. Both male and female patients will be included. Age 18 years or older. Symptoms of heartburn and/or acid regurgitation during at least three nights a week. A total reflux symptom score ≥8 (measured through the GERDQ questionnaire score). Able to wear the Apple Watch on the left wrist. Exclusion Criteria: Complete PPIs non-responders. Nightshift workers Surgery of the esophagus or stomach. Regular use of sleep medication (benzodiazepines) or medication which affect gastrointestinal motility (e.g. prokinetics or opioids) that cannot be stopped during the duration of the trial. Severe and clinically unstable concomitant disease (e.g. liver, cardiovascular or lung disease, neurological or psychiatric disorders, cancer or AIDS and other endocrine disorders) Patients with obstructive sleep apnea or esophageal motility disorders. Pregnant or lactating women.
Sites / Locations
- Amsterdam UMCRecruiting
Arms of the Study
Arm 1
Experimental
Sleep positional therapy by using the LEFT smartwatch app